Unlock stock picks and a broker-level newsfeed that powers Wall Street.

OTC Markets EXMKT - Delayed Quote USD

TRANSNATIONAL CANNABIS LTD (TRCNF)

0.0010
0.0000
(0.00%)
As of April 30 at 4:00:00 PM EDT. Market Open.
Loading Chart for TRCNF
  • Previous Close 0.0001
  • Open 0.0001
  • Bid --
  • Ask --
  • Day's Range 0.0001 - 0.0001
  • 52 Week Range 0.0000 - 0.0010
  • Volume 38,159
  • Avg. Volume 819
  • Market Cap (intraday) 739,106
  • Beta (5Y Monthly) -89.68
  • PE Ratio (TTM) --
  • EPS (TTM) -3.2200
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

TRANSNATIONAL CANNABIS LTD, through its subsidiaries, engages in the cannabis business in Canada and internationally. It holds a license to cultivate, manufacture, supply, hold, import, export, and transport cannabis and derivative products; and engages in procuring and distributing medical cannabis products and cannabis derivatives. The company has strategic partnerships with Green Tree International Inc., Auxly Cananbis Group Inc., Affinity Alpha Unit, Authentic Brands Group, and Biotii Technologies Corp. The company was formerly known as ICC International Cannabis Corp. and changed its name to TRANSNATIONAL CANNABIS LTD in February 2020. TRANSNATIONAL CANNABIS LTD was incorporated in 2006 and is headquartered in Vancouver, Canada.

www.intlcannabiscorp.com

--

Full Time Employees

February 28

Fiscal Year Ends

Recent News: TRCNF

View More

Performance Overview: TRCNF

Trailing total returns as of 5/1/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

TRCNF
9,900.00%
S&P 500 (^GSPC)
4.45%

1-Year Return

TRCNF
900.00%
S&P 500 (^GSPC)
11.98%

3-Year Return

TRCNF
9,900.00%
S&P 500 (^GSPC)
36.01%

5-Year Return

TRCNF
86.30%
S&P 500 (^GSPC)
98.53%

Compare To: TRCNF

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: TRCNF

View More

Valuation Measures

Annual
As of
  • Market Cap

    --

  • Enterprise Value

    --

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -58.25%

  • Return on Equity (ttm)

    -177.06%

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    -139.68M

  • Diluted EPS (ttm)

    -3.2200

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    651.92k

  • Total Debt/Equity (mrq)

    69.14%

  • Levered Free Cash Flow (ttm)

    -44.93M

Research Analysis: TRCNF

View More

Company Insights: TRCNF

Research Reports: TRCNF

View More

People Also Watch